Sfoglia per Autore
Characterization and structural analysis of HIV-1 integrase conservation
2009-01-01 CECCHERINI SILBERSTEIN, F; Malet, I; D'Arrigo, R; Antinori, A; Marcelin, A; Perno, Cf
Historical resistance profile helps to predict salvage failure
2009-01-01 Zaccarelli, M; Lorenzini, P; CECCHERINI SILBERSTEIN, F; Tozzi, V; Forbici, F; Gori, C; Trotta, M; Boumis, E; Narciso, P; Perno, Cf; Antinori, A
Dynamics of NRTI resistance mutations during therapy interruption
2009-01-01 Trignetti, M; Sing, T; Svicher, V; Santoro, M; Forbici, F; D'Arrigo, R; Bellocchi, M; Santoro, M; Marconi, P; Zaccarelli, M; Trotta, M; Bellagamba, R; Narciso, P; Antinori, A; Lengauer, T; Perno, Cf; CECCHERINI SILBERSTEIN, F
The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes
2009-03-01 Svicher, V; Gori, C; Trignetti, M; Visca, M; Micheli, V; Bernassola, M; Salpini, R; Gubertini, G; Longo, R; Niero, F; CECCHERINI SILBERSTEIN, F; De Sanctis, G; Spanò, A; Cappiello, G; Perno, Cf
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients
2009-06-01 Santoro, M; Bertoli, A; Lorenzini, P; CECCHERINI SILBERSTEIN, F; Gianotti, N; Mussini, C; Torti, C; Di Perri, G; Barbarini, G; Bini, T; Melzi, S; Caramello, P; Maserati, R; Narciso, P; Micheli, V; Antinori, A; Perno, Cf
Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure
2009-06-01 Zaccarelli, M; Lorenzini, P; Tozzi, V; Forbici, F; CECCHERINI SILBERSTEIN, F; Gori, C; D'Arrigo, R; Trotta, M; Narciso, P; Perno, Cf; Antinori, A
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev
2009-07-01 Svicher, V; Alteri, C; D'Arrigo, R; Laganà, A; Trignetti, M; Lo Caputo, S; Callegaro, A; Maggiolo, F; Mazzotta, F; Ferro, A; Dimonte, S; Aquaro, S; di Perri, G; Bonora, S; Tommasi, C; Trotta, M; Narciso, P; Antinori, A; Perno, Cf; CECCHERINI SILBERSTEIN, F
Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism Leu-214 on replication capacity and drug susceptibility
2009-08-01 Puertas, M; Buzon, M; Artese, A; Alcaro, S; Menendez Arias, L; Perno, Cf; Clotet, B; CECCHERINI SILBERSTEIN, F; Martinez Picado, J
Resistance to novel drug classes
2009-11-01 Marcelin, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Calvez, V
Computational analysis of Human Immunodeficiency Virus (HIV) Type-1 reverse transcriptase crystallographic models based on significant conserved residues found in Highly Active Antiretroviral Therapy (HAART)-treated patients
2010-01-01 Alcaro, S; Artese, A; CECCHERINI SILBERSTEIN, F; Chiarella, V; Dimonte, S; Ortuso, F; Perno, Cf
Computational analysis of Human Immunodeficiency Virus (HIV) Type-1 reverse transcriptase crystallographic models based on significant conserved residues found in Highly Active Antiretroviral Therapy (HAART)-treated patients.
2010-01-01 Alcaro, S; Artese, A; CECCHERINI SILBERSTEIN, F; Chiarella, V; Dimonte, S; Ortuso, F; Perno, Cf
Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test
2010-01-01 Zaccarelli, M; Antinori, A; Cozzi Lepri, A; Mussini, C; Palamara, G; Santoro, M; Spagnuolo, V; Monforte, A; Perno, Cf; CECCHERINI SILBERSTEIN, F
Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir
2010-03-01 Tommasi, C; CECCHERINI SILBERSTEIN, F; D'Arrigo, R; Bellagamba, R; Tempestilli, M; Dessì, C; Santoro, M; Forbici, F; Nicastri, E; Pucillo, L; Perno, Cf; Narciso, P
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group
2010-07-01 Svicher, V; D'Arrigo, R; Alteri, C; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bonn, I; Bruzzone, B; Callegaro, A; Cammarota, R; Canducci, F; CECCHERINI SILBERSTEIN, F; Clementi, M; Monforte, A; De Luca, A; Di Biagio, A; Di Gianbenedetto, S; Di Perri, G; Di Pietro, M; Fabeni, L; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Giacometti, A; Gori, A; Leoncini, F; Maggiolo, F; Maserati, R; Mazzotta, F; Micheli, V; Meini, G; Monno, L; Mussini, C; Nozza, S; Paolucci, S; Parisi, S; Pecorari, M; Pizzi, D; Quirino, T; Re, M; Rizzardini, G; Santangelo, R; Soria, A; Stazi, F; Sterrantino, G; Turriziani, O; Viscoli, C; Vullo, V; Lazzarin, A; Perno, Cf
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors
2010-09-01 CECCHERINI SILBERSTEIN, F; Van Baelen, K; Armenia, D; Trignetti, M; Rondelez, E; Fabeni, L; Scopelliti, F; Pollicita, M; Van Wesenbeeck, L; Van Eygen, V; Dori, L; Sarmati, L; Aquaro, S; Palamara, G; Andreoni, M; Stuyver, L; Perno, Cf
The use of human immunodeficiency virus resistance tests in clinical practice
2010-10-01 CECCHERINI SILBERSTEIN, F; Cento, V; Calvez, V; Perno, Cf
Rapid prediction of sustained virological response in patients chronically infected with HCV by evaluation of RNA decay 48h after the start of treatment with pegylated interferon and ribavirin
2010-10-01 Parruti, G; Polilli, E; Sozio, F; Cento, V; Pieri, A; Di Masi, F; Mercurio, F; Tontodonati, M; Mazzotta, E; CECCHERINI SILBERSTEIN, F; Manzoli, L; Perno, Cf
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors
2010-11-01 CECCHERINI SILBERSTEIN, F; Malet, I; Fabeni, L; Dimonte, S; Svicher, V; D'Arrigo, R; Artese, A; Costa, G; Bono, S; Alcaro, S; Monforte, A; Katlama, C; Calvez, V; Antinori, A; Marcelin, A; Perno, Cf
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens.
2010-11-01 Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens
2010-11-01 Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2009 | Characterization and structural analysis of HIV-1 integrase conservation | CECCHERINI SILBERSTEIN, F; Malet, I; D'Arrigo, R; Antinori, A; Marcelin, A; Perno, Cf | Articolo su rivista | |
| 1-gen-2009 | Historical resistance profile helps to predict salvage failure | Zaccarelli, M; Lorenzini, P; CECCHERINI SILBERSTEIN, F; Tozzi, V; Forbici, F; Gori, C; Trotta, M; Boumis, E; Narciso, P; Perno, Cf; Antinori, A | Articolo su rivista | |
| 1-gen-2009 | Dynamics of NRTI resistance mutations during therapy interruption | Trignetti, M; Sing, T; Svicher, V; Santoro, M; Forbici, F; D'Arrigo, R; Bellocchi, M; Santoro, M; Marconi, P; Zaccarelli, M; Trotta, M; Bellagamba, R; Narciso, P; Antinori, A; Lengauer, T; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 1-mar-2009 | The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes | Svicher, V; Gori, C; Trignetti, M; Visca, M; Micheli, V; Bernassola, M; Salpini, R; Gubertini, G; Longo, R; Niero, F; CECCHERINI SILBERSTEIN, F; De Sanctis, G; Spanò, A; Cappiello, G; Perno, Cf | Articolo su rivista | |
| 1-giu-2009 | Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients | Santoro, M; Bertoli, A; Lorenzini, P; CECCHERINI SILBERSTEIN, F; Gianotti, N; Mussini, C; Torti, C; Di Perri, G; Barbarini, G; Bini, T; Melzi, S; Caramello, P; Maserati, R; Narciso, P; Micheli, V; Antinori, A; Perno, Cf | Articolo su rivista | |
| 1-giu-2009 | Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure | Zaccarelli, M; Lorenzini, P; Tozzi, V; Forbici, F; CECCHERINI SILBERSTEIN, F; Gori, C; D'Arrigo, R; Trotta, M; Narciso, P; Perno, Cf; Antinori, A | Articolo su rivista | |
| 1-lug-2009 | Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev | Svicher, V; Alteri, C; D'Arrigo, R; Laganà, A; Trignetti, M; Lo Caputo, S; Callegaro, A; Maggiolo, F; Mazzotta, F; Ferro, A; Dimonte, S; Aquaro, S; di Perri, G; Bonora, S; Tommasi, C; Trotta, M; Narciso, P; Antinori, A; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 1-ago-2009 | Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism Leu-214 on replication capacity and drug susceptibility | Puertas, M; Buzon, M; Artese, A; Alcaro, S; Menendez Arias, L; Perno, Cf; Clotet, B; CECCHERINI SILBERSTEIN, F; Martinez Picado, J | Articolo su rivista | |
| 1-nov-2009 | Resistance to novel drug classes | Marcelin, A; CECCHERINI SILBERSTEIN, F; Perno, Cf; Calvez, V | Articolo su rivista | |
| 1-gen-2010 | Computational analysis of Human Immunodeficiency Virus (HIV) Type-1 reverse transcriptase crystallographic models based on significant conserved residues found in Highly Active Antiretroviral Therapy (HAART)-treated patients | Alcaro, S; Artese, A; CECCHERINI SILBERSTEIN, F; Chiarella, V; Dimonte, S; Ortuso, F; Perno, Cf | Articolo su rivista | |
| 1-gen-2010 | Computational analysis of Human Immunodeficiency Virus (HIV) Type-1 reverse transcriptase crystallographic models based on significant conserved residues found in Highly Active Antiretroviral Therapy (HAART)-treated patients. | Alcaro, S; Artese, A; CECCHERINI SILBERSTEIN, F; Chiarella, V; Dimonte, S; Ortuso, F; Perno, Cf | Articolo su rivista | |
| 1-gen-2010 | Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test | Zaccarelli, M; Antinori, A; Cozzi Lepri, A; Mussini, C; Palamara, G; Santoro, M; Spagnuolo, V; Monforte, A; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 1-mar-2010 | Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir | Tommasi, C; CECCHERINI SILBERSTEIN, F; D'Arrigo, R; Bellagamba, R; Tempestilli, M; Dessì, C; Santoro, M; Forbici, F; Nicastri, E; Pucillo, L; Perno, Cf; Narciso, P | Articolo su rivista | |
| 1-lug-2010 | Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group | Svicher, V; D'Arrigo, R; Alteri, C; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bonn, I; Bruzzone, B; Callegaro, A; Cammarota, R; Canducci, F; CECCHERINI SILBERSTEIN, F; Clementi, M; Monforte, A; De Luca, A; Di Biagio, A; Di Gianbenedetto, S; Di Perri, G; Di Pietro, M; Fabeni, L; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Giacometti, A; Gori, A; Leoncini, F; Maggiolo, F; Maserati, R; Mazzotta, F; Micheli, V; Meini, G; Monno, L; Mussini, C; Nozza, S; Paolucci, S; Parisi, S; Pecorari, M; Pizzi, D; Quirino, T; Re, M; Rizzardini, G; Santangelo, R; Soria, A; Stazi, F; Sterrantino, G; Turriziani, O; Viscoli, C; Vullo, V; Lazzarin, A; Perno, Cf | Articolo su rivista | |
| 1-set-2010 | Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors | CECCHERINI SILBERSTEIN, F; Van Baelen, K; Armenia, D; Trignetti, M; Rondelez, E; Fabeni, L; Scopelliti, F; Pollicita, M; Van Wesenbeeck, L; Van Eygen, V; Dori, L; Sarmati, L; Aquaro, S; Palamara, G; Andreoni, M; Stuyver, L; Perno, Cf | Articolo su rivista | |
| 1-ott-2010 | The use of human immunodeficiency virus resistance tests in clinical practice | CECCHERINI SILBERSTEIN, F; Cento, V; Calvez, V; Perno, Cf | Articolo su rivista | |
| 1-ott-2010 | Rapid prediction of sustained virological response in patients chronically infected with HCV by evaluation of RNA decay 48h after the start of treatment with pegylated interferon and ribavirin | Parruti, G; Polilli, E; Sozio, F; Cento, V; Pieri, A; Di Masi, F; Mercurio, F; Tontodonati, M; Mazzotta, E; CECCHERINI SILBERSTEIN, F; Manzoli, L; Perno, Cf | Articolo su rivista | |
| 1-nov-2010 | Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors | CECCHERINI SILBERSTEIN, F; Malet, I; Fabeni, L; Dimonte, S; Svicher, V; D'Arrigo, R; Artese, A; Costa, G; Bono, S; Alcaro, S; Monforte, A; Katlama, C; Calvez, V; Antinori, A; Marcelin, A; Perno, Cf | Articolo su rivista | |
| 1-nov-2010 | Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens. | Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf | Articolo su rivista | |
| 1-nov-2010 | Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens | Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile